Conclusion

Advancements on all levels of proteomics make it possible to integrate proteomics into clinical applications and thereby complement the missing piece of the actual phenotype in molecular diagnostics. Integrating proteomics into the MTB can aid in tumor stratification and the identification of personalized therapeutic strategies.
We emphasize the merits of data integration which enables more detailed stratification, classification, and diagnosis based on multiple layers of molecular information. Data integration promotes a more precise and comprehensive understanding of the underlying molecular pathomechanisms and potential therapeutic targets for complex tumor cases.
The frequent discussions within the MTB further promote this integrative approach and drive both research advancements and clinical applications paving the way toward precision medicine.